A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma

Myung Sun Kim, Titas Banerjee, Andy Chen, Alexey Danilov, Renee MacKinnon, Bria Thurlow, Sujata Thakurta, Kirsten Orand, Catherine Degnin, Byung Park, Stephen E. Spurgeon

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalLeukemia and Lymphoma
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this